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Abstract
Cholesterol synthesized in the body or ingested is an essential lipid component for human survival from our
earliest life. Newborns ingest about 34 times the amount per body weight through mother’s milk compared
to the dietary intake of adults. A birth level of 1.7 mmol/L plasma total cholesterol will increase to 44.5
mmol/L during the nursing period and continue to increase from adulthood around 40% throughout life.
Coronary artery disease and other metabolic disorders are strongly associated with low-density lipoprotein
(LDL) and high-density lipoprotein (HDL) cholesterol as well as triacylglycerol concentration. Milk fat
contains a broad range of fatty acids and some have a negative impact on the cholesterol rich lipoproteins.
The saturated fatty acids (SFAs), such as palmitic acid (C16:0), myristic acid (C14:0), and lauric acid (C12:0),
increase total plasma cholesterol, especially LDL, and constitute 11.3 g/L of bovine milk, which is 44.8% of
total fatty acid in milk fat. Replacement of dairy SFA and trans-fatty acids with polyunsaturated fatty acids
decreases plasma cholesterol, especially LDL cholesterol, and is associated with a reduced risk of
cardiovascular disease. Available data shows different effects on lipoproteins for different dairy products
and there is uncertainty as to the impact a reasonable intake amount of dairy items has on cardiovascular
risk. The aim of this review is to elucidate the effect of milk components and dairy products on total
cholesterol, LDL, HDL, and the LDL/HDL quotients. Based on eight recent randomized controlled trials of
parallel or cross-over design and recent reviews it can be concluded that replacement of saturated fat mainly
(but not exclusively) derived from high-fat dairy products with low-fat dairy products lowers LDL/HDL
cholesterol and total/HDL cholesterol ratios. Whey, dairy fractions enriched in polar lipids, and techniques
such as fermentation, or fortification of cows feeding can be used to produce dairy products with more
beneficial effects on plasma lipid profile.
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C
holesterol is an essential lipid component in cell
membranes and a precursor of bioactive lipids
such as bile acids and steroid hormones. Plasma
cholesterol levels are also a well-known risk factor for
cardiovascular disease (CVD). Mortality in the Western
world is still caused to a high extent by CVD and a large
amount of data related to CVD and other metabolic
diseases concern our intake of fat. Two types of dietary
fatty acids raise plasma cholesterol  saturated fatty acids
(SFAs), mainly palmitic acid (C16:0), and trans-fatty
acids (tFAs). Epidemiological as well as clinical data have
shown that elevated low-density lipoprotein (LDL)
cholesterol, especially small dense LDL particles, to-
gether with reduced high-density lipoprotein (HDL)
cholesterol are associated with the risk of development
of CVD. From 60 selected trials, Mensink et al. (1)
summarized the effects of dietary fats on total cholesterol
to HDL cholesterol ratios and concluded that replacing
tFAs with unsaturated fatty acids gives the single most
effective improvement in plasma lipids. Also, replacement
of SFAwith cis-unsaturated fatty acids reduces CVD risk
(2, 3). One of the oldest and longest dietary intervention
studies in the Nordic countries was the North Karelia
Project, which started in the early 1970s. The main goal
was to reduce the number of cardiovascular deaths by
implementing a health promoting program on a large
population. A major factor with high impact on this
study was the change in intake of fat quality from butter
to more unsaturated fat, which led to a 40% reduction in
cholesterol concentrations (4, 5). There are prospective
cohort studies and reviews (69) describing the effect of
dairy fat on plasma cholesterol composition and the
consensus is that there is no general relation between
dairy intake and cardiovascular risk. Therefore, an
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dairy products in a balanced diet promotes health in
other ways that outweigh the cholesterol raising effects.
The aim of this review is to report an update on recent
results from intervention studies with dairy products and
their effects on cholesterol containing lipoproteins, and
also to put current knowledge about milk components in
relation to effects on plasma cholesterol.
Selection strategy
This review is primarily based on relevant original articles
and recent reviews available in PubMed using the search
words ‘dairy intake,’ ‘milk fat,’ ‘cholesterol,’ and ‘human,’
in combination with ‘cardiovascular risk’ or ‘cardiovas-
cular disease,’ published from 2003, but with a focus on
the recent 5 years. Additionally selected older publica-
tions are included to support the topic. The studies
presented in Table 1 are randomized controlled trials
performed from 2003 on the effects of different dairy
products on plasma lipids with significant outcome.
Neonatal aspects
Milk is an optimal and natural food for a newborn baby.
It is sometimes argued in adult nutrition that milk is a
‘natural’ food and could therefore not be harmful. Thus,
there is reason to comment on the differences in
cholesterol metabolism between adults and suckling
babies. Cord blood has a different lipoprotein profile
compared to adults. It contains one-third of the LDL
concentration and one-half of the HDL concentration.
At birth, LDL cholesterol and apolipoprotein B (apoB)
concentrations are negatively associated with gestational
age and total cholesterol concentration is around 1.67
mmol/L. During the first 5 days of nursing, the choles-
terol concentration increases rapidly to the double (10).
The following month the composition of LDL particles is
modulated by the feeding mode. Both total- and LDL-
cholesterol concentrations are higher in breastfed babies
than formula-fed babies and total cholesterol reaches
almost 4 mmol/L for breastfed babies and around
3.5 mmol/L for formula-fed babies. The fat content in
human milk and also its composition varies during the
lactation period, whereas the cholesterol concentration
decreases with the stages of lactation (11, 12). The daily
cholesterol intake of 1520 mg/kg is around 34 times the
corresponding intake for adults. The intake of cholesterol
in newborns and probably also the cholesterol synthesis
subsequently match the need for cholesterol during rapid
organ growth and the expansion of membrane cholesterol
pools. Normal levels of plasma cholesterol for children
and adolescents aged 219 years are 45 mmol/L and
from 20 to 70 years of age, the plasma cholesterol
increases by 3045%. Subsequently, the need for dietary
cholesterol is not the same when bovine milk and dairy
products in general become an important part of basic
food intake in adolescence and adulthood. It is also
worth emphasizing that bovine milk differs from breast
milk in that it contains rumen-derived short-chain fatty
acids (C4:0C8:0)  3.5 times as much calcium and 2.5
times as much proteins  lower concentrations of
unsaturated fatty acids and sphingomyelin, and more
SFAs (12, 13).
Intervention studies
Numerous intervention studies have been published
comparing the cholesterolemic effects of different dairy
products on both healthy individuals and individuals with
some metabolic disorder. Whereas the results for butter
are consentient, trials with milk, fermented products, and
cheese are less conclusive. In a study designed to compare
the effects of the physical state of milk fat on plasma
cholesterol diets providing 20E% (of which 16E% is SFA)
as dairy fat either as whole milk, butter or hard cheese
were compared (14) (Table 1). In this strictly controlled
cross-over study on 14 healthy young men, they found no
support for a hypocholesterolemic milk factor. The
cheese diet resulted in 5 and 7% lower total cholesterol
and LDL concentrations compared to butter, possibly as
a consequence of the higher amount of calcium and
fermentation of cheese. The overall decrease in triglycer-
ides (TG) of 1620% after all three diets could be
explained by the lower content of carbohydrates com-
pared to their normal diet. Others have obtained similar
results (15) (Table 1). In a study by Biong et al. (16)
(Table 1), the authors compared intake of cheese with
butter enriched with casein or egg protein. The results
from this study showed that at equal fat and protein
content, cheese decreased total plasma cholesterol by 3%,
but the LDL:HDL ratio was not different between the
diets. Once again, the calcium content was higher in the
cheese diet, which could promote the excretion of fat as
calcium soaps. Also, one of the bacterial strains used in
the fermentation of the cheese was found to have
hypocholesterolemic effects on rats (17). Cheese is still a
source of SFA and in a randomized controlled clinical
trial with cross-over design, 31 subjects with mild
hypercholesterolemia consumed 65 g of cheese per day
made from either milk fat or rapeseed oil (18). After
intervention, the total serum cholesterol and LDL
cholesterol was reduced by 6.7 and 7% after 2 weeks
and by 5 and 6.4% after 4 weeks with the rapeseed oil-
based cheese. The HDL cholesterol concentrations were
not significantly changed. A more recent intervention
study undertaken simultaneously in Finland, Norway,
and Sweden included 120 men and women with less than
two symptoms of the metabolic syndrome (19) (Table 1).
In this 6-month randomized parallel-group study the
participants were allocated to a milk group or control
group. The milk group was instructed to include 35
defined portions of dairy products in their daily diet while
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dairy group consumed 300 g more milk or yoghurt, 20 g
more cheese and 5 g more butter than control group. The
result was a moderate increase of 4% in serum total
cholesterol in the milk group compared to control. A
moderate increase in apoB in the milk group, especially in
Sweden, was positively associated with the increase in
C15:0, a biomarker of milk fat. The explanation might be
the intake of more full-fat dairy products in the Swedish
participants, whereas Norwegian and Finnish partici-
pants ate preferably low- to moderate-fat products (19).
Butter affects postprandial lipemia differently com-
pared to vegetable oils. When 4250 g of butter in a meal
was compared with 3540 g of olive oil, postprandial TG
was lower with butter (20, 21) and in another study the
size of the chylomicrons were smaller (22). This was seen
both in healthy subjects and in overweight persons with
non-insulin-dependent diabetes. By contrast, after-meals
containing 100 g of butter comparedwith 80 g ofolive oil,
the postprandial TG concentrations are higher and the
HDL cholesterol lower with butter both in healthy and
type 2 diabetic individuals (23, 24). Whereas the presence
of short-chain fatty acids in butter commonly explains
the lower increase in postprandial plasma lipids in
relation to other oils, the opposite relation occurring at
a high lipid load has not been unraveled.
Factors in dairy products that affect plasma
cholesterol
Milk contains a large number of bioactive compounds,
but milk fat has the largest impact on plasma lipids. The
lipid pattern in dairy fat is very complicated and more
than 400 different fatty acids have been identified. About
70% of dairy fat contains SFAs of which the majority
(45%) are of 1216 carbon chain length and 2.7% are
tFAs (13), and these have the ability to raise plasma
cholesterol. Except for the concentration of different
types of plasma lipoproteins that can be affected, their
size and composition will change in response to different
types of dietary fat. For example, it is suggested that
larger sizes of lipoproteins are less atherogenic than
smaller sizes (25) and some of the fatty acids typically
found in milk fat have been associated with less dense
LDL particles (26).
Other milk components like proteins, calcium, and
lactose have been suggested to affect lipid metabolism
directly or indirectly, but the strongest impact on plasma
lipids emerges from the intake of milk fat.
Table 1. The table presents intervention studies in which the aims were to investigate the effects of dairy products on plasma cholesterol
concentrations and in which signiﬁcant changes in cholesterol concentrations were seen
Reference
Subjects (menwomen)
and intervention time Dairy product (daily intake)
Significant effect on plasma
cholesterol
Tholstrup et al. [14] 14 men 3 weeks 1.5 L milk, 64 g butter, 205 g cheese Butter diet 7.9% increase LDL
compared to cheese
Nestel et al. [15] 145 4 weeks 40 g butter or Cheddar cheese Total and LDL cholesterol 9 and 15% higher
after butter
Biong et al. [16] 913 3 weeks 150 g cheese, 52 g butterprotein Total cholesterol 3% lower with cheese vs.
butter meals
Wennersberg et al. [19] 4180 6 months 300 g more milk, 20 g more cheese,
5 g more butter than controls
Total cholesterol 4% higher in dairy group vs.
control
Motard-Be ´langer et al. [40] 48 men 4 weeks Ruminant tFA high (10.2 g/2,500 kcal)
or moderate (4.2 g/2,500 kcal),
industrial tFA high or low (2.2 g/
2,500 kcal) tFA
Total and LDL cholesterol increased 3 and 2%
with high ruminant tFA and 6 and 5% with
industrial tFA vs. control
Chardigny et al. [38] 1921 3 weeks Butter or cheese for ruminant tFA,
cookies for industrial tFA. 4% of daily
energy/67% of daily fat energy
In women: HDL cholesterol 6% lower with
industrial tFA vs. ruminant tFA. LDL was 15%
higher with ruminant tFA.Total cholesterol
11% increased with ruminant tFA
Andrade et al. [74] 34 women 4 weeks 125 g3 fermented milk or plain
yoghurt
Decrease of LDL (12,5 and 16%). Also
decrease HDL 1012%
Seidel et al. [77] 1615 13 weeks (a) 250 g regular milk, 150 g regular
yoghurt and butter for cooking, (b) the
same as a with modified milk, or (c)
same as a with margarine
HDL increased 15%. LDL and LDL/HDL
decreased 11% and 17.5% after modified milk
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After absorption, the predominant dairy SFA palmitic
acid (C16:0), but also myristic acid (C14:0) and lauric
acid (C12:0) are preferentially directed to TG formation
rather than to phospholipid acylation. These three long-
chain fatty acids raise total cholesterol, but their effects
on LDL:HDL ratios are different. Palmitic acid is the
major SFA in the diet and also in milk fat with a content
of about 30%. Palmitic acid raises the LDL cholesterol
more than it raises HDL cholesterol (27). Myristic acid
represents 11% of the dairy fatty acids and increase total
cholesterol as much as palmitic acid, but does not affect
total cholesterol:HDL ratio (1, 28). Lauric acid is the
most potent fatty acid in raising plasma total cholesterol,
but dairy content is only 3.3%. The increase in HDL
cholesterol induced by lauric acid is higher than the
increase in LDL and thus the total cholesterol:HDL ratio
was decreased when lauric acid was used to replace
carbohydrates (1). Stearic acid represents 12% of the
dairy fatty acids and improves the plasma cholesterol
profile by decreasing total/HDL cholesterol ratio com-
pared to other SFAs. But compared to polyunsaturated
fatty acids (PUFA), stearic acid increases LDL and
decreases HDL and increase total/ HDL ratio (29). Other
SFAs are short- and medium-chain length and are mainly
considered to be cholesterol neutral. At a certain amount
of SFA intake, an increase in both LDL and HDL
cholesterol can be seen, especially if the intake of
unsaturated fatty acids is low (30, 31). In a recent meta-
analysis of prospective epidemiological studies, intake of
SFA and risk of CVD was studied (32). Six studies found
a significant positive association between SFA intake and
CVD, and 10 studies found no significant association.
The author states, however, that there is a need for
further studies to evaluate the CVD risks when replacing
SFA with other specific nutrients.
The outcome of the meta-analysis (32) does not differ
between men and women, but there are studies included
suggesting that men andwomen have a different risk ratio
from consumption of SFA with a slightly higher risk for
men (33). In a recent meta-analysis of randomized
controlled trials the pooled results from eight trials
demonstrated a significant reduction in CVD events by
replacing SFA with PUFA (34). In summary, if the target
is to reduce plasma cholesterol, especially LDL, the
intake of SFAs from dairy and other products should
be replaced by low-fat dairy products or PUFA.
Unsaturated fatty acids
Although unsaturated fatty acids are a minor component
of milk fat, monounsaturated fatty acids (MUFA), such
as oleic acid (C18:1), is the second most abundant fatty
acid representing 23% by weight in Swedish dairy milk
(13). Dairy products together with meat and hydroge-
nated oils are actually a major source of MUFA in
Scandinavia. Oleic acid is considered favorable since it
has a cholesterol- and TG-lowering effect compared with
SFA, and meals containing olive oil increase the size of
postprandial TG-rich lipoproteins more than meals with
butter (35), which is considered to be less atherogenic. By
increasing MUFA at the expense of SFA, which can be
done with modification of dairy products, larger post-
prandial chylomicrons can be formed (36). The overall
effect of MUFA from dairy products is, however, not
clear since the intake of oleic acid from other dietary
products is high.
Trans-fatty acids (tFA)
Of the seasonal variation of fat in bovine milk, tFA have
the largest variation and their concentrations are more
than twice as high in summer milk as in winter milk
(37), e.g. the variation in Swedish cows is from 0.6 to
3.9% with an approximate medium value of 2.7% (13).
The dietary tFA of industrial origin that humans
consume from eating cookies, pastries, and microwave
popcorn are shown in many studies to be detrimental to
our vascular health (38, 39). Milk fat is the major source
of natural conjugated linoleic acid (CLA) and the
predominant isoform is cis-9, trans-11 CLA, which
accounts for 8590%. The minor trans-10, cis-12 CLA
isomer has been shown to have a more detrimental effect
on plasma cholesterol than cis-9, trans-11 CLA since it
increases total/HDL and LDL/HDL ratios. The effect of
natural tFA, such as CLA and trans 18:1, found in dairy
products and meat and of industrial tFA on human
plasma lipids has been investigated. The study by
Motard-Belanger et al. (40) suggests that ruminant tFA
have little impact on cholesterol homeostasis (Table 1).
In this 4-week randomized, cross-over-controlled study
on 38 healthy men, they found that a moderate intake of
ruminant tFA had neutral effects on plasma lipids,
whereas high amounts of both ruminant and industrial
tFA increased both the total plasma cholesterol by 3 and
2%, respectively, and LDL cholesterol by 6 and 4.6%. In
a quantitative review of 39 carefully selected original
articles, only including randomized controlled trials in a
parallel or cross-over design, the authors conclude that
all tFA increases the LDL/HDL ratio in a linear fashion
(41). The effect of ruminant tFA and CLA on the LDL/
HDL ratio was less than that of industrial tFA. In the
TRANSFACT study, a randomized controlled trial, 46
healthy subjects consumed 1112 g/day of either indus-
trial or ruminant tFA (38) (Table 1). The major finding
was that the natural sources of tFA significantly
increases HDL- and LDL-cholesterol concentrations in
women but not in men, and the HDL-lowering effect is
mainly associated with industrial tFA. The differences in
cholesterol concentrations observed in women were also
associated with the size of lipoproteins and tFA from
natural sources increases the proportion of larger
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decrease the plasma cholesterol concentration and an
improvement of the LDL/HDL ratio is likely. The
mechanisms underlying the gender effects and type of
isoforms need further investigation.
Medium-chain fatty acids (MCFA)
Medium-chain fatty acids (MCFA) are caproic acid
(hexanoic acid, C6:0), caprylic acid (octanoic acid,
C8:0), and capric acid (decanoic acid, C10:0). MCFA
are present at about 6.8, 6.9, 6.6, and 7.3% (of total fatty
acid) in butter, milk, yogurt, and cheese, respectively (42).
MCFA are rapidly hydrolyzed in the gastrointestinal tract
(GI-tract) and are directly transported to the liver and
into the mitochondria of the hepatocytes for oxidation
(43) but some, especially decanoic acid (C10:0) will be
incorporated to chylomicron TG. Several studies report
effects such as increased lipid oxidation, decreased body
weight, increased thermogenesis and energy expenditure
from consumption of MCFA and a few studies report a
lowering of total cholesterol, LDL, and an increase of
LDL particle size (44, 45). Whether the long-term effects
on plasma cholesterol levels and an improvement of
LDL:HDL ratios are caused by weight reduction or are
an actual effect of the MCFA itself is not fully clarified.
In a randomized controlled intervention study on 17
healthy individuals, a high intake of 70 g of MCFA per
day for 3 weeks was, however, detrimental to plasma
lipids with a 12% increase both in LDL cholesterol and
LDL/HDL ratio (46). In another study, intake of
moderate amounts (10 E%) of MCFA for 6 weeks had
no effect on plasma cholesterol concentrations (47). The
intake of MCFA from dairy products will be of little
significance with regard to concentration, whereas the
interaction with other dairy lipid components might have
an effect on plasma lipids, but no such data are available.
Polar lipids
The milk fat globule membrane contains 23% of polar
lipids, mostly phosphatidylcholine (PC) (3035%), but
also sphingomyelin (25%). Some studies showed that
human milk has higher levels of sphingomyelin (SM)
than of PC (11). In a Western diet, the intake of SM
from bovine milk is approximately 412 mg/dl (48).
Studies on rats and mice have shown that dietary SM
from milk inhibits cholesterol absorption (4951). We
recently performed a 4-week intervention study on 48
healthy subjects where participants consumed a sphingo-
myelin-enriched milk drink every day with their habitual
diet. Our main hypothesis of a cholesterol-lowering effect
was unconfirmed but there was a trend that the SM-
enriched drink counteracted the effects emerging from an
increased energy intake. The increased plasma concentra-
tions of cholesterol and TG caused by the elevated energy
intake, mainly caused by the test drinks, were counter-
acted by the SM-enriched drink (52). There are several
potential mechanisms by which dairy products enriched
in polar lipids can promote vascular health and reduce
risk, such as affecting the cholesterol absorption and
being a source of unsaturated fatty acids. Presently, there
are only few studies within this area and human inter-
vention trials are warranted.
Proteins
There are studies supporting the hypothesis that dairy
products have anti-obesity effects and the bioactive
compounds such as calcium and proteins augmenting
this effect havebeen discussed (53, 54). In the 1990s, it was
suggested that whey proteins had more hypocholestero-
lemic effect than casein and soy proteins in rats (55, 56). A
decade later, four peptides formed from tryptic cleavage of
bovine b-lactoglobulin: IIAEK, GLDIQK, ALPMH, and
VYVEELKPTPEGDLEILLQK were found to inhibit
cholesterol absorption by increasing fecal output of
steroid. Of the four peptides, IIAEK had a higher effect
thanb-sitosterol(57).Inarecent invitrostudyonahuman
intestinal cell line (NCI-H716), the effects both of the
specific amino acids leucine, isoleucine and valine, and of
whey, skim milk and casein on expression of lipid-
regulating genes was examined (58). It was found that
isoleucine, leucine, valine, and whey down-regulated
Niemann-Pick C1-like 1 (NPC1L1), a protein carrier
with a critical role for intestinal cholesterol absorption.
They conclude that dairy products such as whey, with a
high content of branched-chain amino acids can have an
effect on cholesterol absorption and possibly also on the
plasma cholesterol concentration. The hypocholesterole-
miceffectofwhey hasnowbeenconfirmedalsoinhumans
(59). A comparison of whey proteins and casein with
glucose as control was recently conducted on overweight/
obese subjects. After 12 weeks of daily intake, results
showed that whey significantly decreased total and LDL
cholesterol compared to both casein and control. Further-
more, Nyberg et al. (60) found evidence of an acid
sphingomyelinase present in human milk, which may
generate ceramide from hydrolysis of milk SM in the
stomach, and recent investigations in human intestinal
Caco-2 cells showed that the presence of ceramide
inhibitedthecellularuptakeofcholesterolmoreeffectively
than that of SM (61). Taken together, whey proteins but
not casein seems to have hypocholesterolemic effects by
inhibiting intestinal absorption of cholesterol. Whether
acid sphingomyelinase is present in bovine milk and, if so,
has any effect on digestion of dairy SM in the stomach is
not known.
Dairy products and plasma cholesterol levels
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Calcium as a food supplement has been shown to increase
HDL cholesterol and decrease total- and LDL-cholesterol
concentrations, thereby improve the HDL:LDL ratio (62
64). Dairy products are the richest source of calcium and
the concentration is highest in hard cheese. It was shown
in an intervention study on 18 healthy men that milk and
yoghurt containing different concentrations of calcium
decreased postprandial lipid response in a dose-dependent
manner (65). The results by Lorenzen et al. (65) and from
other trials (66) indicate that an increase in dairy calcium
promotes fecal fat excretion, but support as to whether
this affects plasma cholesterol concentrations is lacking.
Lactose
It is hypothesized that lactose can affect lipemia by
promoting calcium absorption. In humans, it has been
hypothesized whether lactose is a risk factor for ischemic
heart disease (IHD) in a study based on data from 43
countries (67). The study compares populations with
different grades of lactose malabsorption and milk intake.
They propose that there is a correlation between popula-
tions with high occurrence of lactose malabsorption and
lower incidence of mortality from IHD. This is, however,
contradicted in several studies where the risk ratios for
myocardial infarctions are B1 with a high milk consump-
tion (68, 69). In older human studies, ingesting 80 g of
lactose per day as whey resulted in a decreased serum
cholesterol(70).Furthermore,50g/dayofaddedlactoseto
patientswith CVD significantly reduced serumcholesterol
over a 3-week period (71). In a study comparing high-fat-
fed mice with mice fed both high-fat and lactose, plasma
lipidsweresignificantlylowerinthegroupfedhighfatwith
lactose. The body weight gain was also slightly lower for
mice-fed lactose, but cholesterol levels were not investi-
gated (72). There seems to be no newer human data on
plasma cholesterol after intake of lactose-free dairy
productscomparedtothelactose-containingcounterparts.
Fermented dairy products
The effects of fermented dairy products have been studied
since the 1970s. The first studies showed that unpasteur-
ized yoghurt decreased serum cholesterol by 59%. Later,
results from some studies showed no effects of fermented
products, but this was explained by the fact that the
subjects in the study had a baseline cholesterol concen-
tration of B5.0 mmol/L. Since then, many studies have
displayed hypocholesterolemic effects on hypercholester-
olemic subjects (73). In a recent study on 34 women, an
intake of 125 g of fermented milk three times a day for 4
weeks decreased plasma LDL cholesterol by 12.516%.
There was also a significant decrease of HDL cholesterol
of 1012% (74) (Table 1). It is concluded that many
strains of fermentation bacteria, but not all are viable
enough to reach the lower part of the gut and exert effects
on the microbiota, thereby increasing the amount of
propionate that has a cholesterol-lowering effect. The
second effect by which bacteria may influence cholesterol
level is by hydrolyzing glycine and taurin-conjugated bile
acids (15, 75). By deconjugating bile acids, the excretion
of bile acids in feces is increased, which promote the use
of cholesterol for synthesis of new bile acids. The use of
fermented milk instead of normal milk may therefore be a
method to reduce or maintain the plasma cholesterol
levels, but the effects on LDL/HDL ratio should be
further investigated.
Modified dairy products
Of the main milk components, fat is the most sensitive to
dietary changes (76). Except for seasonal variations in
bovine milk fat composition, fortified feeding of cows
may affect the milk fat composition. By feeding cows 400
g of rapeseed oil, Seidel et al. (77) were able to reduce
SFA (C12:0, C14:0, and C16:0) by 20% and increase the
milk content of unsaturated fatty acids by about 33%. In
the following intervention study divided into three
periods of 18 days each, both normo- and hyperlipidemic
subjects increased their HDL cholesterol and reduced the
LDL cholesterol after the period with modified milk.
This was not seen after periods with regular fat or
margarine (77) (Table 1). In this study, normolipidemic
subjects responded more sensitively to changes in HDL
and LDL cholesterol than those with hyperlipemia. By
modification of cow-feeding regimes, the fatty acid
composition of milk might be adjusted to contain less
SFA and consequently more healthy dairy products can
be produced.
Conclusion
The impact on our plasma lipid levels from dairy intake is
depending on amounts, fat concentrations, and also on
gender, age, and metabolic capacity of the consumer.
Certain dairy products are also often part of a health-
conscious lifestyle, which promotes maintaining or loss of
weight with a subsequent improvement of plasma cho-
lesterol profile. Also, when it comes to choices of food
within the same group, women tend to choose low-fat
dairy products more often than men do.
Despite the complexity of this nutrient, we find some
conclusions that can be made regarding milk fat and
cholesterol.
Dairy fat contains a high concentration of SFA and
since dairy products are a considerable part of habitual
diets, they have also generally been a target for restriction
advice in order to reduce intake of saturated fat. Intake of
saturated fat with chain length C12C16 and tFA
increases plasma LDLwhich is an independent risk factor
for CVD. The presence of tFA in dairy fat increases the
LDL/HDL linearly with dose and, theoretically, by low-
ering the tFA intake by 0.5% of energy, this might reduce
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predominant fatty acid in milk fat and increases the
LDL:HDL ratio morethan lauric and myristic acids do. It
can be calculated how much a change in SFA intake will
affect the LDL cholesterol and the risk of developing
CVD. By substituting 30 g of butter per day containing
about 11 g of SFA with a margarine rich in unsaturated
fatty acids containing 2.4 g of SFA, would reduce LDL
cholesterol by 0.2 mmol/L and subsequently reduce the
risk of CVD in the order of 610%. In light of this, the
increase of 4.9 g/day SFA intake in the milk group in the
study by Wennersberg resulted in a slight increase in LDL
cholesterol of 0.1 mmol/L. In some cohorts with a rather
high baseline intake of dairy fat, correlations between
dairy intake and plasma cholesterol would therefore be
scarce. However, dairy SFA is not only C12C16, but
around 25% is represented by short- and medium-chain
fatty acids, which have the ability to affect the digestion of
milk fat already in the stomach through digestion by
gastric lipase and isomerization of fatty acids in the
partially hydrolyzed TG. It is necessary to distinguish
between the effects of butter and other dairy products,
since butter increases plasma cholesterol, especially LDL
cholesterol, more than other dairy products. Dairy fat
raises both LDL and HDL cholesterol, but the evidence
for a detrimental effect of high plasma LDL levels is
stronger than the positive effects from an increased HDL
concentration. Intervention studies that focus on reducing
dairy fat intake and other studies aswell, must be aware of
the effect on HDL cholesterol, both regarding size and
concentration, since a reduction in HDL size and
concentration may not improve health or reduce CVD
risks.
On the basis of controlled and randomized dietary
intervention studies with different dairy products and
recent meta-analyses of both epidemiological and con-
trolled studies, the present approach to limit the intake of
high-fat dairy products on behalf of low-fat products is
unchallenged. A reasonable intake of cheese, low-fat and
fermented milk reduced plasma cholesterol levels, mainly
LDL cholesterol, in the order of 315% compared to
butter or other high-fat dairy products, but not compared
to nutrients containing more PUFA. The levels of milk
components, e.g. MUFA, MCFA, and other polar lipids,
have little individual impact on plasma cholesterol
concentrations, but there are only few studies for
consensus and no studies on concerted action of selected
components. There is still no satisfactory explanation for
the term ‘milk factor,’ although some unknown mechan-
ism might yet be found in the interaction between
calcium, proteins, lactose, and fatty acids.
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